Factor VIII Dosing Calculator

Loading...

%
%

References

  1. Annemarie Thompson. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.. Circulation, 2024
  2. Lynn Malec. Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A.. The New England journal of medicine, 2024
  3. Suely M Rezende. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology.. Journal of thrombosis and haemostasis : JTH, 2024
  4. I. van Moort. Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.. The Lancet. Haematology, 2021
  5. R. Klamroth. Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: Results from the phase 3 PROPEL study.. Blood, 2020
  6. H. Hazendonk. A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients. Haematologica, 2016
  7. J. Mahlangu. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.. Blood, 2014
  8. S. Henrard. Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients. Haematologica, 2013
  9. S. Gouw. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.. Blood, 2013
  10. S. Björkman. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.. Blood, 2012